{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:30:27Z","timestamp":1786350627301,"version":"build-2736575974"},"reference-count":247,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01904-8","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:44:41Z","timestamp":1786344281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein\u2013protein interaction-mediated signaling networks in ischemic stroke: from molecular mechanisms to therapeutic strategies"],"prefix":"10.1038","author":[{"given":"Yi-yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-yu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-ju","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"1904_CR1","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0140-6736(24)01410-7","volume":"404","author":"TN Nguyen","year":"2024","unstructured":"Nguyen TN, Abdalkader M, Fischer U, Qiu Z, Nagel S, Chen HS, et al. Endovascular management of acute stroke. Lancet. 2024;404:1265\u201378.","journal-title":"Lancet"},{"key":"1904_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","volume":"67","author":"MA Moskowitz","year":"2010","unstructured":"Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67:181\u201398.","journal-title":"Neuron"},{"key":"1904_CR3","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1056\/NEJMoa2400314","volume":"390","author":"S Li","year":"2024","unstructured":"Li S, Gu HQ, Li H, Wang X, Jin A, Guo S, et al. Reteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2024;390:2264\u201373.","journal-title":"N Engl J Med"},{"key":"1904_CR4","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1161\/STROKEAHA.125.050402","volume":"56","author":"A Sarraj","year":"2025","unstructured":"Sarraj A, Yoshimura S, Thomalla G, Huo X, Arquizan C, Yoo AJ, et al. Mechanical thrombectomy for large ischemic stroke: a critical appraisal of evidence from 6 randomized controlled trials. Stroke. 2025;56:1917\u201327.","journal-title":"Stroke"},{"key":"1904_CR5","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","volume":"403","author":"NA Hilkens","year":"2024","unstructured":"Hilkens NA, Casolla B, Leung TW, de Leeuw FE. Stroke. Lancet. 2024;403:2820\u201336.","journal-title":"Lancet"},{"key":"1904_CR6","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1212\/WNL.0000000000012781","volume":"97","author":"V Saini","year":"2021","unstructured":"Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97:S6\u2013S16.","journal-title":"Neurology"},{"key":"1904_CR7","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1161\/STROKEAHA.124.045755","volume":"55","author":"V Yogendrakumar","year":"2024","unstructured":"Yogendrakumar V, Vandelanotte S, Mistry EA, Hill MD, Coutts SB, Nogueira RG, et al. Emerging adjuvant thrombolytic therapies for acute ischemic stroke reperfusion. Stroke. 2024;55:2536\u201346.","journal-title":"Stroke"},{"key":"1904_CR8","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s12035-022-03169-8","volume":"60","author":"YY Zhang","year":"2023","unstructured":"Zhang YY, Yang XY, Liu HQ, Zhang Z, Hu CP, Peng J, et al. The weakened interaction between HECTD4 and GluN2B in ischemic stroke promotes calcium overload and brain injury through a mechanism involving the decrease of GluN2B and MALT1 ubiquitination. Mol Neurobiol. 2023;60:1563\u201379.","journal-title":"Mol Neurobiol"},{"key":"1904_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06135-x","volume":"14","author":"T Li","year":"2023","unstructured":"Li T, Zhao L, Li Y, Dang M, Lu J, Lu Z, et al. PPM1K mediates metabolic disorder of branched-chain amino acid and regulates cerebral ischemia-reperfusion injury by activating ferroptosis in neurons. Cell Death Dis. 2023;14:634.","journal-title":"Cell Death Dis"},{"key":"1904_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02991-8","volume":"21","author":"S Chen","year":"2024","unstructured":"Chen S, Pan J, Gong Z, Wu M, Zhang X, Chen H, et al. Hypochlorous acid derived from microglial myeloperoxidase could mediate high-mobility group box 1 release from neurons to amplify brain damage in cerebral ischemia-reperfusion injury. J Neuroinflammation. 2024;21:70.","journal-title":"J Neuroinflammation"},{"key":"1904_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10557-021-07231-w","volume":"37","author":"YY Zhang","year":"2023","unstructured":"Zhang YY, Tian J, Peng ZM, Liu B, Peng YW, Zhang XJ, et al. Caspofungin suppresses brain cell necroptosis in ischemic stroke rats via up-regulation of Pellino3. Cardiovasc Drugs Ther. 2023;37:9\u201323.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1904_CR12","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/nm.2245","volume":"16","author":"L Zhou","year":"2010","unstructured":"Zhou L, Li F, Xu HB, Luo CX, Wu HY, Zhu MM, et al. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med. 2010;16:1439\u201343.","journal-title":"Nat Med"},{"key":"1904_CR13","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/STROKEAHA.107.506048","volume":"39","author":"HS Sun","year":"2008","unstructured":"Sun HS, Doucette TA, Liu Y, Fang Y, Teves L, Aarts M, et al. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Stroke. 2008;39:2544\u201353.","journal-title":"Stroke"},{"key":"1904_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2019.03.004","volume":"127","author":"KM DeMars","year":"2019","unstructured":"DeMars KM, Yang C, Candelario-Jalil E. Neuroprotective effects of targeting BET proteins for degradation with dBET1 in aged mice subjected to ischemic stroke. Neurochem Int. 2019;127:94\u2013102.","journal-title":"Neurochem Int"},{"key":"1904_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101931","volume":"87","author":"YY Zhang","year":"2023","unstructured":"Zhang YY, Li XS, Ren KD, Peng J, Luo XJ. Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases. Ageing Res Rev. 2023;87:101931.","journal-title":"Ageing Res Rev"},{"key":"1904_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401085","volume":"11","author":"J Chen","year":"2024","unstructured":"Chen J, Yang J, Chu J, Chen KH, Alt J, Rais R, et al. The SWELL1 channel promotes ischemic brain damage by mediating neuronal swelling and glutamate toxicity. Adv Sci. 2024;11:e2401085.","journal-title":"Adv Sci"},{"key":"1904_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.neuint.2008.12.017","volume":"54","author":"M Sun","year":"2009","unstructured":"Sun M, Zhao Y, Gu Y, Xu C. Inhibition of nNOS reduces ischemic cell death through down-regulating calpain and caspase-3 after experimental stroke. Neurochem Int. 2009;54:339\u201346.","journal-title":"Neurochem Int"},{"key":"1904_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbrc.2012.03.039","volume":"420","author":"JH Di","year":"2012","unstructured":"Di JH, Li C, Yu HM, Zheng JN, Zhang GY. nNOS downregulation attenuates neuronal apoptosis by inhibiting nNOS-GluR6 interaction and GluR6 nitrosylation in cerebral ischemic reperfusion. Biochem Biophys Res Commun. 2012;420:594\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1904_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/01.STR.29.3.705","volume":"29","author":"T Kristi\u00e1n","year":"1998","unstructured":"Kristi\u00e1n T, Siesj\u00f6 BK. Calcium in ischemic cell death. Stroke. 1998;29:705\u201318.","journal-title":"Stroke"},{"key":"1904_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1126\/science.7569905","volume":"269","author":"HC Kornau","year":"1995","unstructured":"Kornau HC, Schenker LT, Kennedy MB, Seeburg PH. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science. 1995;269:1737\u201340.","journal-title":"Science"},{"key":"1904_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11010-012-1280-4","volume":"365","author":"LJ Tang","year":"2012","unstructured":"Tang LJ, Li C, Hu SQ, Wu YP, Zong YY, Sun CC, et al. S-nitrosylation of c-Src via NMDAR-nNOS module promotes c-Src activation and NR2A phosphorylation in cerebral ischemia\/reperfusion. Mol Cell Biochem. 2012;365:363\u201377.","journal-title":"Mol Cell Biochem"},{"key":"1904_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.niox.2024.10.004","volume":"153","author":"B Guo","year":"2024","unstructured":"Guo B, Ma B, Li M, Li Y, Liang P, Han D, et al. The nitration of SIRT6 aggravates neuronal damage during cerebral ischemia-reperfusion in rat. Nitric Oxide. 2024;153:26\u201340.","journal-title":"Nitric Oxide"},{"key":"1904_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","volume":"140","author":"W Tu","year":"2010","unstructured":"Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell. 2010;140:222\u201334.","journal-title":"Cell"},{"key":"1904_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103214","volume":"24","author":"JE Tullis","year":"2021","unstructured":"Tullis JE, Buonarati OR, Coultrap SJ, Bourke AM, Tiemeier EL, Kennedy MJ, et al. GluN2B S1303 phosphorylation by CaMKII or DAPK1: no indication for involvement in ischemia or LTP. iScience. 2021;24:103214.","journal-title":"iScience"},{"key":"1904_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2019.11.076","volume":"30","author":"OR Buonarati","year":"2020","unstructured":"Buonarati OR, Cook SG, Goodell DJ, Chalmers NE, Rumian NL, Tullis JE, et al. CaMKII versus DAPK1 binding to GluN2B in ischemic neuronal cell death after resuscitation from cardiac arrest. Cell Rep. 2020;30:1\u20138.e4.","journal-title":"Cell Rep"},{"key":"1904_CR26","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1523\/JNEUROSCI.0157-10.2010","volume":"30","author":"P Kurup","year":"2010","unstructured":"Kurup P, Zhang Y, Xu J, Venkitaramani DV, Haroutunian V, Greengard P, et al. Abeta-mediated NMDA receptor endocytosis in Alzheimer\u2019s disease involves ubiquitination of the tyrosine phosphatase STEP61. J Neurosci. 2010;30:5948\u201357.","journal-title":"J Neurosci"},{"key":"1904_CR27","doi-asserted-by":"publisher","first-page":"E4736","DOI":"10.1073\/pnas.1609702113","volume":"113","author":"S Won","year":"2016","unstructured":"Won S, Incontro S, Nicoll RA, Roche KW. PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61. Proc Natl Acad Sci USA. 2016;113:E4736\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1904_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay3302","volume":"370","author":"J Yan","year":"2020","unstructured":"Yan J, Bengtson CP, Buchthal B, Hagenston AM, Bading H. Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants. Science. 2020;370:eaay3302.","journal-title":"Science"},{"key":"1904_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119260","volume":"340","author":"C Liu","year":"2025","unstructured":"Liu C, Zhang J, Mao K, Xu H, He Y. Astragalus membranaceus-Carthamus tinctorius herb pair antagonizes parthanatos in cerebral ischemia\/reperfusion injury via regulating PARP-1\/TAX1BP1-mediated mitochondrial respiratory chain complex I. J Ethnopharmacol. 2025;340:119260.","journal-title":"J Ethnopharmacol"},{"key":"1904_CR30","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","volume":"187","author":"B Qiu","year":"2024","unstructured":"Qiu B, Zandkarimi F, Bezjian CT, Reznik E, Soni RK, Gu W, et al. Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell. 2024;187:1177\u201390.e18.","journal-title":"Cell"},{"key":"1904_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102667","volume":"104","author":"P Wen","year":"2025","unstructured":"Wen P, Sun Z, Gou F, Wang J, Fan Q, Zhao D, et al. Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders. Ageing Res Rev. 2025;104:102667.","journal-title":"Ageing Res Rev"},{"key":"1904_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116894","volume":"177","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yuan H, Shen D, Liu S, Kong W, Zheng K, et al. Artemisinin attenuated ischemic stroke-induced pyroptosis by inhibiting ROS\/TXNIP\/NLRP3\/Caspase-1 signaling pathway. Biomed Pharmacother. 2024;177:116894.","journal-title":"Biomed Pharmacother"},{"key":"1904_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123625","volume":"372","author":"L Wang","year":"2025","unstructured":"Wang L, Liu HR, Liu HQ, Li XS, Tang TT, Wang KJ, et al. SETD1B promotes brain cell ferroptosis in ischemic stroke mice via increasing H3K4me3 enrichment on the Tfrc promoter. Life Sci. 2025;372:123625.","journal-title":"Life Sci"},{"key":"1904_CR34","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.1074\/jbc.M704997200","volume":"283","author":"AT B\u00e4umer","year":"2008","unstructured":"B\u00e4umer AT, Ten Freyhaus H, Sauer H, Wartenberg M, Kappert K, Schnabel P, et al. Phosphatidylinositol 3-kinase-dependent membrane recruitment of Rac-1 and p47phox is critical for alpha-platelet-derived growth factor receptor-induced production of reactive oxygen species. J Biol Chem. 2008;283:7864\u201376.","journal-title":"J Biol Chem"},{"key":"1904_CR35","doi-asserted-by":"publisher","first-page":"31859","DOI":"10.1074\/jbc.M501882200","volume":"280","author":"T Kawahara","year":"2005","unstructured":"Kawahara T, Ritsick D, Cheng G, Lambeth JD. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J Biol Chem. 2005;280:31859\u201369.","journal-title":"J Biol Chem"},{"key":"1904_CR36","doi-asserted-by":"publisher","first-page":"18583","DOI":"10.1074\/jbc.M310268200","volume":"279","author":"B B\u00e1nfi","year":"2004","unstructured":"B\u00e1nfi B, Tirone F, Durussel I, Knisz J, Moskwa P, Moln\u00e1r GZ, et al. Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). J Biol Chem. 2004;279:18583\u201391.","journal-title":"J Biol Chem"},{"key":"1904_CR37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.devcel.2008.12.015","volume":"16","author":"EM Ha","year":"2009","unstructured":"Ha EM, Lee KA, Park SH, Kim SH, Nam HJ, Lee HY, et al. Regulation of DUOX by the Galphaq-phospholipase Cbeta-Ca2+ pathway in Drosophila gut immunity. Dev Cell. 2009;16:386\u201397.","journal-title":"Dev Cell"},{"key":"1904_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/cvr\/cvr275","volume":"93","author":"MR Schroeter","year":"2012","unstructured":"Schroeter MR, Stein S, Heida NM, Leifheit-Nestler M, Cheng IF, Gogiraju R, et al. Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9. Cardiovasc Res. 2012;93:170\u201380.","journal-title":"Cardiovasc Res"},{"key":"1904_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.yjmcc.2009.02.021","volume":"46","author":"AP Halestrap","year":"2009","unstructured":"Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol. 2009;46:821\u201331.","journal-title":"J Mol Cell Cardiol"},{"key":"1904_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s10020-024-00847-2","volume":"30","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Li W, Ni L, Wang T, Huang Y, Yu Y, et al. Icariin improves oxidative stress injury during ischemic stroke via inhibiting mPTP opening. Mol Med. 2024;30:77.","journal-title":"Mol Med"},{"key":"1904_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172617","volume":"861","author":"KD Ren","year":"2019","unstructured":"Ren KD, Liu WN, Tian J, Zhang YY, Peng JJ, Zhang D, et al. Mitochondrial E3 ubiquitin ligase 1 promotes brain injury by disturbing mitochondrial dynamics in a rat model of ischemic stroke. Eur J Pharmacol. 2019;861:172617.","journal-title":"Eur J Pharmacol"},{"key":"1904_CR42","doi-asserted-by":"publisher","first-page":"450","DOI":"10.6026\/97320630009450","volume":"9","author":"N Chauhan","year":"2013","unstructured":"Chauhan N, Chaunsali L, Deshmukh P, Padmanabhan B. Analysis of dimerization of BTB-IVR domains of Keap1 and its interaction with Cul3, by molecular modeling. Bioinformation. 2013;9:450\u20135.","journal-title":"Bioinformation"},{"key":"1904_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1021\/tx700302s","volume":"21","author":"G Rachakonda","year":"2008","unstructured":"Rachakonda G, Xiong Y, Sekhar KR, Stamer SL, Liebler DC, Freeman ML. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem Res Toxicol. 2008;21:705\u201310.","journal-title":"Chem Res Toxicol"},{"key":"1904_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102852","volume":"66","author":"YY Sun","year":"2023","unstructured":"Sun YY, Zhu HJ, Zhao RY, Zhou SY, Wang MQ, Yang Y, et al. Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2\/HO-1 pathway in MCAO mice. Redox Biol. 2023;66:102852.","journal-title":"Redox Biol"},{"key":"1904_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2023.115368","volume":"237","author":"D Zhao","year":"2023","unstructured":"Zhao D, Geng C, Liu X, Jin X, Zhao Z, Liu Y, et al. Photoelectrochemical detection of superoxide anions released from mitochondria in HepG2 cells based on the synergistic effect of MnO2@Co3O4 core-shell p-n heterojunction. Biosens Bioelectron. 2023;237:115368.","journal-title":"Biosens Bioelectron"},{"key":"1904_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12035-024-04288-0","volume":"62","author":"L Wang","year":"2025","unstructured":"Wang L, Li X, Chen L, Mei S, Shen Q, Liu L, et al. Mitochondrial uncoupling protein-2 ameliorates ischemic stroke by inhibiting ferroptosis-induced brain injury and neuroinflammation. Mol Neurobiol. 2025;62:501\u201317.","journal-title":"Mol Neurobiol"},{"key":"1904_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01973-4","volume":"17","author":"H Fan","year":"2020","unstructured":"Fan H, Tang HB, Chen Z, Wang HQ, Zhang L, Jiang Y, et al. Inhibiting the HMGB1-RAGE axis prevents pro-inflammatory macrophage\/microglia polarization and affords neuroprotection after spinal cord injury. J Neuroinflammation. 2020;17:295.","journal-title":"J Neuroinflammation"},{"key":"1904_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114229","volume":"149","author":"O Du","year":"2025","unstructured":"Du O, Yan YL, Yang HY, Yang YX, Wu AG, Guo YK, et al. ALPK1 signaling pathway activation by HMGB1 drives microglial pyroptosis and ferroptosis and brain injury after acute ischemic stroke. Int Immunopharmacol. 2025;149:114229.","journal-title":"Int Immunopharmacol"},{"key":"1904_CR49","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1161\/01.STR.0000226465.84561.cb","volume":"37","author":"KB Holven","year":"2006","unstructured":"Holven KB, Halvorsen B, Bjerkeli V, Dam\u00e5s JK, Retterst\u00f8l K, M\u00f8rkrid L, et al. Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects. Stroke. 2006;37:1731\u20136.","journal-title":"Stroke"},{"key":"1904_CR50","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.neuroscience.2010.07.011","volume":"170","author":"VA Dinapoli","year":"2010","unstructured":"Dinapoli VA, Benkovic SA, Li X, Kelly KA, Miller DB, Rosen CL, et al. Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat. Neuroscience. 2010;170:633\u201344.","journal-title":"Neuroscience"},{"key":"1904_CR51","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.14336\/AD.2023.0226","volume":"14","author":"Q Suo","year":"2023","unstructured":"Suo Q, Deng L, Chen T, Wu S, Qi L, Liu Z, et al. Optogenetic activation of astrocytes reduces blood-brain barrier disruption via IL-10 in stroke. Aging Dis. 2023;14:1870\u201386.","journal-title":"Aging Dis"},{"key":"1904_CR52","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12017-020-08613-3","volume":"22","author":"S Momenabadi","year":"2020","unstructured":"Momenabadi S, Vafaei AA, Bandegi AR, Zahedi-Khorasani M, Mazaheri Z, Vakili A. Oxytocin reduces brain injury and maintains blood-brain barrier integrity after ischemic stroke in mice. Neuromolecular Med. 2020;22:557\u201371.","journal-title":"Neuromolecular Med"},{"key":"1904_CR53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21:263\u20139.","journal-title":"Nat Med"},{"key":"1904_CR54","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1016\/j.molcel.2023.11.015","volume":"83","author":"S Zheng","year":"2023","unstructured":"Zheng S, Que X, Wang S, Zhou Q, Xing X, Chen L, et al. ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation. Mol Cell. 2023;83:4570\u201385.e7.","journal-title":"Mol Cell"},{"key":"1904_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"key":"1904_CR56","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41420-023-01406-0","volume":"9","author":"K Sun","year":"2023","unstructured":"Sun K, Guo Z, Zhang J, Hou L, Liang S, Lu F, et al. Inhibition of TRADD ameliorates chondrocyte necroptosis and osteoarthritis by blocking the RIPK1-TAK1 pathway and restoring autophagy. Cell Death Discov. 2023;9:109.","journal-title":"Cell Death Discov"},{"key":"1904_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2757-z","volume":"587","author":"D Xu","year":"2020","unstructured":"Xu D, Zhao H, Jin M, Zhu H, Shan B, Geng J, et al. Modulating TRADD to restore cellular homeostasis and inhibit apoptosis. Nature. 2020;587:133\u20138.","journal-title":"Nature"},{"key":"1904_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41423-021-00810-9","volume":"19","author":"B Wu","year":"2022","unstructured":"Wu B, Qiang L, Zhang Y, Fu Y, Zhao M, Lei Z, et al. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-\u03baB signaling. Cell Mol Immunol. 2022;19:276\u201389.","journal-title":"Cell Mol Immunol"},{"key":"1904_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52076-0","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Moro S, Shostak K, O\u2019Reilly FJ, Donzeau M, Graziadei A, et al. Molecular mechanism of IKK catalytic dimer docking to NF-\u03baB substrates. Nat Commun. 2024;15:7692.","journal-title":"Nat Commun"},{"key":"1904_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02501-2","volume":"19","author":"L Luo","year":"2022","unstructured":"Luo L, Liu M, Fan Y, Zhang J, Liu L, Li Y, et al. Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4\/NF\u03baB\/NLRP3 signaling pathway in cerebral ischemic mice. J Neuroinflammation. 2022;19:141.","journal-title":"J Neuroinflammation"},{"key":"1904_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02918-3","volume":"20","author":"JN Nguyen","year":"2023","unstructured":"Nguyen JN, Mohan EC, Pandya G, Ali U, Tan C, Kofler JK, et al. CD13 facilitates immune cell migration and aggravates acute injury but promotes chronic post-stroke recovery. J Neuroinflammation. 2023;20:232.","journal-title":"J Neuroinflammation"},{"key":"1904_CR62","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/acschemneuro.2c00139","volume":"13","author":"A Berselli","year":"2022","unstructured":"Berselli A, Alberini G, Benfenati F, Maragliano L. Computational assessment of different structural models for claudin-5 complexes in blood-brain barrier tight junctions. ACS Chem Neurosci. 2022;13:2140\u201353.","journal-title":"ACS Chem Neurosci"},{"key":"1904_CR63","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1039\/D1FO03062K","volume":"13","author":"E Hibino","year":"2022","unstructured":"Hibino E, Goda N, Hisada M, Tenno T, Hiroaki H. Direct inhibition of the first PDZ domain of ZO-1 by glycyrrhizin is a possible mechanism of tight junction opening of Caco-2 cells. Food Funct. 2022;13:1953\u201364.","journal-title":"Food Funct"},{"key":"1904_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s40478-025-02021-z","volume":"13","author":"J Pareja","year":"2025","unstructured":"Pareja J, Aydin S, Zbinden M, Bouillet E, Zollinger N, Theivendram V, et al. Lack of junctional adhesion molecule (JAM)-B traps CD8 T cells in CNS border zones and ameliorates autoimmune neuroinflammation. Acta Neuropathol Commun. 2025;13:117.","journal-title":"Acta Neuropathol Commun"},{"key":"1904_CR65","first-page":"1344","volume":"15","author":"JJ Pan","year":"2024","unstructured":"Pan JJ, Qi L, Wang L, Liu C, Song Y, Mamtilahun M, et al. M2 microglial extracellular vesicles attenuated blood-brain barrier disruption via MiR-23a-5p in cerebral ischemic mice. Aging Dis. 2024;15:1344\u201356.","journal-title":"Aging Dis"},{"key":"1904_CR66","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/antiox11081455","volume":"11","author":"YC Li","year":"2022","unstructured":"Li YC, Li Y, Zhang YN, Zhao Q, Zhang PL, Sun MR, et al. Muscone and (+)-borneol cooperatively strengthen CREB induction of claudin 5 in IL-1\u03b2-induced endothelium injury. Antioxidants. 2022;11:1455.","journal-title":"Antioxidants"},{"key":"1904_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2011.11.052","volume":"1436","author":"R Xu","year":"2012","unstructured":"Xu R, Feng X, Xie X, Zhang J, Wu D, Xu L. HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9. Brain Res. 2012;1436:13\u20139.","journal-title":"Brain Res"},{"key":"1904_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1790-z","volume":"10","author":"S Heimer","year":"2019","unstructured":"Heimer S, Knoll G, Schulze-Osthoff K, Ehrenschwender M. Raptinal bypasses BAX, BAK, and BOK for mitochondrial outer membrane permeabilization and intrinsic apoptosis. Cell Death Dis. 2019;10:556.","journal-title":"Cell Death Dis"},{"key":"1904_CR69","doi-asserted-by":"publisher","first-page":"14782","DOI":"10.1073\/pnas.1417253111","volume":"111","author":"X Jiang","year":"2014","unstructured":"Jiang X, Jiang H, Shen Z, Wang X. Activation of mitochondrial protease OMA1 by Bax and Bak promotes cytochrome c release during apoptosis. Proc Natl Acad Sci USA. 2014;111:14782\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1904_CR70","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1523\/JNEUROSCI.5119-13.2014","volume":"34","author":"L Pei","year":"2014","unstructured":"Pei L, Shang Y, Jin H, Wang S, Wei N, Yan H, et al. DAPK1-p53 interaction converges necrotic and apoptotic pathways of ischemic neuronal death. J Neurosci. 2014;34:6546\u201356.","journal-title":"J Neurosci"},{"key":"1904_CR71","doi-asserted-by":"publisher","first-page":"17941","DOI":"10.1074\/jbc.274.25.17941","volume":"274","author":"A Saleh","year":"1999","unstructured":"Saleh A, Srinivasula SM, Acharya S, Fishel R, Alnemri ES. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem. 1999;274:17941\u20135.","journal-title":"J Biol Chem"},{"key":"1904_CR72","doi-asserted-by":"publisher","first-page":"11549","DOI":"10.1074\/jbc.274.17.11549","volume":"274","author":"H Zou","year":"1999","unstructured":"Zou H, Li Y, Liu X, Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999;274:11549\u201356.","journal-title":"J Biol Chem"},{"key":"1904_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113476","volume":"42","author":"P Davidovich","year":"2023","unstructured":"Davidovich P, Higgins CA, Najda Z, Longley DB, Martin SJ. cFLIP(L) acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8\/FADD\/RIPK1 NF-\u03baB-activating complexes. Cell Rep. 2023;42:113476.","journal-title":"Cell Rep"},{"key":"1904_CR74","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/cdd.2010.135","volume":"18","author":"ZT Schug","year":"2011","unstructured":"Schug ZT, Gonzalvez F, Houtkooper RH, Vaz FM, Gottlieb E. BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ. 2011;18:538\u201348.","journal-title":"Cell Death Differ"},{"key":"1904_CR75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207240119","volume":"119","author":"DA Rodriguez","year":"2022","unstructured":"Rodriguez DA, Quarato G, Liedmann S, Tummers B, Zhang T, Guy C, et al. Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis. Proc Natl Acad Sci USA. 2022;119:e2207240119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1904_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"AQ Chen","year":"2019","unstructured":"Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, et al. Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis. 2019;10:487.","journal-title":"Cell Death Dis"},{"key":"1904_CR77","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/SHK.0000000000001632","volume":"55","author":"J Wang","year":"2021","unstructured":"Wang J, Luan Y, Fan EK, Scott MJ, Li Y, Billiar TR, et al. TBK1\/IKK\u03b5 negatively regulate LPS-Iinduced neutrophil necroptosis and lung inflammation. Shock. 2021;55:338\u201348.","journal-title":"Shock"},{"key":"1904_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15466-8","volume":"11","author":"L Laurien","year":"2020","unstructured":"Laurien L, Nagata M, Sch\u00fcnke H, Delanghe T, Wiederstein JL, Kumari S, et al. Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation. Nat Commun. 2020;11:1747.","journal-title":"Nat Commun"},{"key":"1904_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42255-w","volume":"14","author":"Y Meng","year":"2023","unstructured":"Meng Y, Garnish SE, Davies KA, Black KA, Leis AP, Horne CR, et al. Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization. Nat Commun. 2023;14:6804.","journal-title":"Nat Commun"},{"key":"1904_CR80","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/cdd.2015.169","volume":"23","author":"MC Tanzer","year":"2016","unstructured":"Tanzer MC, Matti I, Hildebrand JM, Young SN, Wardak A, Tripaydonis A, et al. Evolutionary divergence of the necroptosis effector MLKL. Cell Death Differ. 2016;23:1185\u201397.","journal-title":"Cell Death Differ"},{"key":"1904_CR81","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u20135.","journal-title":"Nature"},{"key":"1904_CR82","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","volume":"180","author":"K Wang","year":"2020","unstructured":"Wang K, Sun Q, Zhong X, Zeng M, Zeng H, Shi X, et al. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell. 2020;180:941\u201355.e20.","journal-title":"Cell"},{"key":"1904_CR83","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-04020-1","volume":"599","author":"Z Li","year":"2021","unstructured":"Li Z, Liu W, Fu J, Cheng S, Xu Y, Wang Z, et al. Shigella evades pyroptosis by arginine ADP-riboxanation of caspase-11. Nature. 2021;599:290\u20135.","journal-title":"Nature"},{"key":"1904_CR84","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-023-01349-6","volume":"9","author":"R Hu","year":"2023","unstructured":"Hu R, Liang J, Ding L, Zhang W, Wang Y, Zhang Y, et al. Gasdermin D inhibition ameliorates neutrophil mediated brain damage in acute ischemic stroke. Cell Death Discov. 2023;9:50.","journal-title":"Cell Death Discov"},{"key":"1904_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103223","volume":"74","author":"D Wang","year":"2024","unstructured":"Wang D, Yu X, Gao K, Li F, Li X, Pu H, et al. Sweroside alleviates pressure overload-induced heart failure through targeting CaMK\u2161\u03b4 to inhibit ROS-mediated NF-\u03baB\/NLRP3 in cardiomyocytes. Redox Biol. 2024;74:103223.","journal-title":"Redox Biol"},{"key":"1904_CR86","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221\u20135.","journal-title":"Nature"},{"key":"1904_CR87","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55:1370\u201385.e8.","journal-title":"Immunity"},{"key":"1904_CR88","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He Y, Zeng MY, Yang D, Motro B, N\u00fa\u00f1ez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530:354\u20137.","journal-title":"Nature"},{"key":"1904_CR89","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3390\/jcm10081674","volume":"10","author":"T Wijeratne","year":"2021","unstructured":"Wijeratne T, Sales C. Understanding why post-stroke depression may be the norm rather than the exception: the anatomical and neuroinflammatory correlates of post-stroke depression. J Clin Med. 2021;10:1674.","journal-title":"J Clin Med"},{"key":"1904_CR90","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/861231","volume":"2014","author":"G Olmos","year":"2014","unstructured":"Olmos G, Llad\u00f3 J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014;2014:861231.","journal-title":"Mediators Inflamm"},{"key":"1904_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102679","volume":"62","author":"X Liu","year":"2023","unstructured":"Liu X, Zhang W, Luo J, Shi W, Zhang X, Li Z, et al. TRIM21 deficiency protects against atrial inflammation and remodeling post myocardial infarction by attenuating oxidative stress. Redox Biol. 2023;62:102679.","journal-title":"Redox Biol"},{"key":"1904_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02756-3","volume":"20","author":"XY Yin","year":"2023","unstructured":"Yin XY, Tang XH, Wang SX, Zhao YC, Jia M, Yang JJ, et al. HMGB1 mediates synaptic loss and cognitive impairment in an animal model of sepsis-associated encephalopathy. J Neuroinflammation. 2023;20:69.","journal-title":"J Neuroinflammation"},{"key":"1904_CR93","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41586-024-07220-7","volume":"628","author":"V Jovasevic","year":"2024","unstructured":"Jovasevic V, Wood EM, Cicvaric A, Zhang H, Petrovic Z, Carboncino A, et al. Formation of memory assemblies through the DNA-sensing TLR9 pathway. Nature. 2024;628:145\u201353.","journal-title":"Nature"},{"key":"1904_CR94","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/eurheartj\/ehac684","volume":"44","author":"P Widimsky","year":"2023","unstructured":"Widimsky P, Snyder K, Sulzenko J, Hopkins LN, Stetkarova I. Acute ischaemic stroke: recent advances in reperfusion treatment. Eur Heart J. 2023;44:1205\u201315.","journal-title":"Eur Heart J"},{"key":"1904_CR95","doi-asserted-by":"publisher","first-page":"11625","DOI":"10.1039\/D3NR01071F","volume":"15","author":"K Wang","year":"2023","unstructured":"Wang K, Zhou W, Jin X, Shang X, Wu X, Wen L, et al. Enhanced brain delivery of hypoxia-sensitive liposomes by hydroxyurea for rescue therapy of hyperacute ischemic stroke. Nanoscale. 2023;15:11625\u201346.","journal-title":"Nanoscale"},{"key":"1904_CR96","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/CCM.0000000000004597","volume":"48","author":"F Herpich","year":"2020","unstructured":"Herpich F, Rincon F. Management of acute ischemic stroke. Crit Care Med. 2020;48:1654\u201363.","journal-title":"Crit Care Med"},{"key":"1904_CR97","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s12975-021-00916-2","volume":"12","author":"SH Yang","year":"2021","unstructured":"Yang SH, Liu R. Four decades of ischemic penumbra and its implication for ischemic stroke. Transl Stroke Res. 2021;12:937\u201345.","journal-title":"Transl Stroke Res"},{"key":"1904_CR98","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41582-018-0002-2","volume":"14","author":"JC Baron","year":"2018","unstructured":"Baron JC. Protecting the ischaemic penumbra as an adjunct to thrombectomy for acute stroke. Nat Rev Neurol. 2018;14:325\u201337.","journal-title":"Nat Rev Neurol"},{"key":"1904_CR99","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1161\/STROKEAHA.111.618801","volume":"42","author":"BT Br\u00e5tane","year":"2011","unstructured":"Br\u00e5tane BT, Cui H, Cook DJ, Bouley J, Tymianski M, Fisher M. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke. 2011;42:3265\u201370.","journal-title":"Stroke"},{"key":"1904_CR100","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/jcbfm.2015.16","volume":"35","author":"Y Chen","year":"2015","unstructured":"Chen Y, Brennan-Minnella AM, Sheth S, El-Benna J, Swanson RA. Tat-NR2B9c prevents excitotoxic neuronal superoxide production. J Cereb Blood Flow Metab. 2015;35:739\u201342.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1904_CR101","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","volume":"395","author":"MD Hill","year":"2020","unstructured":"Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM, et al. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet. 2020;395:878\u201387.","journal-title":"Lancet"},{"key":"1904_CR102","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb1498","volume":"13","author":"D Mayor-Nunez","year":"2021","unstructured":"Mayor-Nunez D, Ji Z, Sun X, Teves L, Garman JD, Tymianski M. Plasmin-resistant PSD-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke. Sci Transl Med. 2021;13:eabb1498.","journal-title":"Sci Transl Med"},{"key":"1904_CR103","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2019.02.035","volume":"150","author":"A Bach","year":"2019","unstructured":"Bach A, Clausen BH, Kristensen LK, Andersen MG, Ellman DG, Hansen PBL, et al. Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor. Neuropharmacology. 2019;150:100\u201311.","journal-title":"Neuropharmacology"},{"key":"1904_CR104","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/STROKEAHA.108.538686","volume":"40","author":"F Liu","year":"2009","unstructured":"Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD. Sex differences in caspase activation after stroke. Stroke. 2009;40:1842\u20138.","journal-title":"Stroke"},{"key":"1904_CR105","first-page":"319","volume":"7","author":"B Manwani","year":"2011","unstructured":"Manwani B, McCullough LD. Sexual dimorphism in ischemic stroke: lessons from the laboratory. Women\u2019s Health. 2011;7:319\u201339.","journal-title":"Women\u2019s Health"},{"key":"1904_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-6-33","volume":"6","author":"JT Lang","year":"2008","unstructured":"Lang JT, McCullough LD. Pathways to ischemic neuronal cell death: are sex differences relevant? J Transl Med. 2008;6:33.","journal-title":"J Transl Med"},{"key":"1904_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/srep12157","volume":"5","author":"A Bach","year":"2015","unstructured":"Bach A, Pedersen SW, Dorr LA, Vallon G, Ripoche I, Ducki S, et al. Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ\/PSD-95-PDZ interactions. Sci Rep. 2015;5:12157.","journal-title":"Sci Rep"},{"key":"1904_CR108","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/jnr.24068","volume":"95","author":"DL Wang","year":"2017","unstructured":"Wang DL, Qian XD, Lin YH, Tian BB, Liang HY, Chang L, et al. ZL006 promotes migration and differentiation of transplanted neural stem cells in male rats after stroke. J Neurosci Res. 2017;95:2409\u201319.","journal-title":"J Neurosci Res"},{"key":"1904_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/srep12651","volume":"5","author":"Z Wang","year":"2015","unstructured":"Wang Z, Zhao Y, Jiang Y, Lv W, Wu L, Wang B, et al. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system. Sci Rep. 2015;5:12651.","journal-title":"Sci Rep"},{"key":"1904_CR110","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.7150\/thno.60701","volume":"11","author":"S Ayuso-Dolado","year":"2021","unstructured":"Ayuso-Dolado S, Esteban-Ortega GM, Vidaurre \u00d3G, D\u00edaz-Guerra M. A novel cell-penetrating peptide targeting calpain-cleavage of PSD-95 induced by excitotoxicity improves neurological outcome after stroke. Theranostics. 2021;11:6746\u201365.","journal-title":"Theranostics"},{"key":"1904_CR111","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1021\/acs.jmedchem.4c02772","volume":"68","author":"M Sun","year":"2025","unstructured":"Sun M, Wang L, Cao Q, Wang X, Zhang Y, Guo M, et al. Discovery of HZS60 as a novel brain penetrant NMDAR\/TRPM4 interaction interface inhibitor with improved activity and pharmacokinetic properties for the treatment of cerebral ischemia. J Med Chem. 2025;68:2008\u201343.","journal-title":"J Med Chem"},{"key":"1904_CR112","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1021\/acschemneuro.0c00739","volume":"12","author":"Y Qin","year":"2021","unstructured":"Qin Y, Feng L, Fan X, Zheng L, Zhang Y, Chang L, et al. Neuroprotective effect of N-Cyclohexylethyl-[A\/G]-[D\/E]-X-V peptides on ischemic stroke by blocking nNOS-CAPON interaction. ACS Chem Neurosci. 2021;12:244\u201355.","journal-title":"ACS Chem Neurosci"},{"key":"1904_CR113","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/CIRCULATIONAHA.105.581397","volume":"113","author":"M Zhang","year":"2006","unstructured":"Zhang M, Kho AL, Anilkumar N, Chibber R, Pagano PJ, Shah AM, et al. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation. 2006;113:1235\u201343.","journal-title":"Circulation"},{"key":"1904_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116412","volume":"463","author":"XJ Zhang","year":"2023","unstructured":"Zhang XJ, Li L, Wang AL, Guo HX, Zhao HP, Chi RF, et al. GSK2795039 prevents RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis in doxorubicin-induced heart failure through inhibition of NADPH oxidase-derived oxidative stress. Toxicol Appl Pharmacol. 2023;463:116412.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1904_CR115","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1007\/s12035-020-01989-0","volume":"57","author":"AK Kalvala","year":"2020","unstructured":"Kalvala AK, Kumar R, Sherkhane B, Gundu C, Arruri VK, Kumar A. Bardoxolone methyl ameliorates hyperglycemia induced mitochondrial dysfunction by activating the keap1-Nrf2-ARE pathway in experimental diabetic neuropathy. Mol Neurobiol. 2020;57:3616\u201331.","journal-title":"Mol Neurobiol"},{"key":"1904_CR116","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2016.07.035","volume":"333","author":"K Yamauchi","year":"2016","unstructured":"Yamauchi K, Nakano Y, Imai T, Takagi T, Tsuruma K, Shimazawa M, et al. A novel nuclear factor erythroid 2-related factor 2 (Nrf2) activator RS9 attenuates brain injury after ischemia reperfusion in mice. Neuroscience. 2016;333:302\u201310.","journal-title":"Neuroscience"},{"key":"1904_CR117","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw4597","volume":"5","author":"J Karch","year":"2019","unstructured":"Karch J, Bround MJ, Khalil H, Sargent MA, Latchman N, Terada N, et al. Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. Sci Adv. 2019;5:eaaw4597.","journal-title":"Sci Adv"},{"key":"1904_CR118","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/01616412.2020.1762353","volume":"42","author":"H Deng","year":"2020","unstructured":"Deng H, Zhang S, Ge H, Liu L, Liu L, Feng H, et al. The effect of cyclosporin a on ischemia-reperfusion damage in a mouse model of ischemic stroke. Neurol Res. 2020;42:721\u20139.","journal-title":"Neurol Res"},{"key":"1904_CR119","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1212\/WNL.0000000000001639","volume":"84","author":"N Nighoghossian","year":"2015","unstructured":"Nighoghossian N, Berthez\u00e8ne Y, Mechtouff L, Derex L, Cho TH, Ritzenthaler T, et al. Cyclosporine in acute ischemic stroke. Neurology. 2015;84:2216\u201323.","journal-title":"Neurology"},{"key":"1904_CR120","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/neu.2017.5167","volume":"35","author":"JE Springer","year":"2018","unstructured":"Springer JE, Visavadiya NP, Sullivan PG, Hall ED. Post-injury treatment with NIM811 promotes recovery of function in adult female rats after spinal cord contusion: a dose-response study. J Neurotrauma. 2018;35:492\u20139.","journal-title":"J Neurotrauma"},{"key":"1904_CR121","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/bjp.2008.285","volume":"155","author":"J Reutenauer","year":"2008","unstructured":"Reutenauer J, Dorchies OM, Patthey-Vuadens O, Vuagniaux G, Ruegg UT. Investigation of debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br J Pharmacol. 2008;155:574\u201384.","journal-title":"Br J Pharmacol"},{"key":"1904_CR122","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15:556\u20139.","journal-title":"Nat Chem Biol"},{"key":"1904_CR123","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41590-025-02088-9","volume":"26","author":"S Feng","year":"2025","unstructured":"Feng S, Wierzbowski MC, Hrovat-Schaale K, Dumortier A, Zhang Y, Zyulina M, et al. Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants. Nat Immunol. 2025;26:511\u201323.","journal-title":"Nat Immunol"},{"key":"1904_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117861","volume":"183","author":"R Prakash","year":"2025","unstructured":"Prakash R, Waseem A, Siddiqui AJ, Naime M, Khan MA, Robertson AA, et al. MCC950 mitigates SIRT3-NLRP3-driven inflammation and rescues post-stroke neurogenesis. Biomed Pharmacother. 2025;183:117861.","journal-title":"Biomed Pharmacother"},{"key":"1904_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02674-w","volume":"20","author":"M Bellut","year":"2023","unstructured":"Bellut M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK. Delayed NLRP3 inflammasome inhibition ameliorates subacute stroke progression in mice. J Neuroinflammation. 2023;20:4.","journal-title":"J Neuroinflammation"},{"key":"1904_CR126","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","volume":"46","author":"JE Cabral","year":"2025","unstructured":"Cabral JE, Wu A, Zhou H, Pham MA, Lin S, McNulty R. Targeting the NLRP3 inflammasome for inflammatory disease therapy. Trends Pharmacol Sci. 2025;46:503\u201319.","journal-title":"Trends Pharmacol Sci"},{"key":"1904_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107358","volume":"92","author":"Y Shi","year":"2021","unstructured":"Shi Y, Lv Q, Zheng M, Sun H, Shi F. NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages. Int Immunopharmacol. 2021;92:107358.","journal-title":"Int Immunopharmacol"},{"key":"1904_CR128","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3389\/fphar.2018.01405","volume":"9","author":"C Pellegrini","year":"2018","unstructured":"Pellegrini C, Fornai M, Colucci R, Benvenuti L, D\u2019Antongiovanni V, Natale G, et al. A comparative study on the efficacy of NLRP3 inflammasome signaling inhibitors in a pre-clinical model of bowel inflammation. Front Pharmacol. 2018;9:1405.","journal-title":"Front Pharmacol"},{"key":"1904_CR129","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1177\/0271678X19880161","volume":"40","author":"DN Edwards","year":"2020","unstructured":"Edwards DN, Salmeron K, Lukins DE, Trout AL, Fraser JF, Bix GJ. Integrin \u03b15\u03b21 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke. J Cereb Blood Flow Metab. 2020;40:1695\u2013708.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1904_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacbts.2020.10.003","volume":"6","author":"BJ Beddingfield","year":"2021","unstructured":"Beddingfield BJ, Iwanaga N, Chapagain PP, Zheng W, Roy CJ, Hu TY, et al. The integrin binding peptide, ATN-161, as a novel therapy for SARS-CoV-2 infection. JACC Basic Transl Sci. 2021;6:1\u20138.","journal-title":"JACC Basic Transl Sci"},{"key":"1904_CR131","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s10753-021-01509-9","volume":"44","author":"N Amruta","year":"2021","unstructured":"Amruta N, Bix G. ATN-161 ameliorates ischemia\/reperfusion-induced oxidative stress, fibro-inflammation, mitochondrial damage, and apoptosis-mediated tight junction disruption in bEnd.3 cells. Inflammation. 2021;44:2377\u201394.","journal-title":"Inflammation"},{"key":"1904_CR132","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41418-018-0116-5","volume":"26","author":"X Li","year":"2019","unstructured":"Li X, Zheng L, Xia Q, Liu L, Mao M, Zhou H, et al. A novel cell-penetrating peptide protects against neuron apoptosis after cerebral ischemia by inhibiting the nuclear translocation of annexin A1. Cell Death Differ. 2019;26:260\u201375.","journal-title":"Cell Death Differ"},{"key":"1904_CR133","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1021\/acschemneuro.5c00082","volume":"16","author":"YY Zhang","year":"2025","unstructured":"Zhang YY, Li RF, Tian J, Peng J, Luo XJ. Cerdulatinib improves sensorimotor function and memory ability in mice suffering from ischemic stroke through targeting caspase-3-dependent apoptosis. ACS Chem Neurosci. 2025;16:2248\u201359.","journal-title":"ACS Chem Neurosci"},{"key":"1904_CR134","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.7150\/thno.85390","volume":"13","author":"H Zhou","year":"2023","unstructured":"Zhou H, Yan L, Huang H, Li X, Xia Q, Zheng L, et al. Tat-NTS peptide protects neurons against cerebral ischemia-reperfusion injury via ANXA1 SUMOylation in microglia. Theranostics. 2023;13:5561\u201383.","journal-title":"Theranostics"},{"key":"1904_CR135","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1161\/STROKEAHA.114.006348","volume":"45","author":"X Wang","year":"2014","unstructured":"Wang X, Pei L, Yan H, Wang Z, Wei N, Wang S, et al. Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke. Stroke. 2014;45:3089\u201391.","journal-title":"Stroke"},{"key":"1904_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25427-4","volume":"12","author":"H Yan","year":"2022","unstructured":"Yan H, Sasaki T, Kanki H, Hirata Y, Nishiyama K, Hisada S, et al. MDMX elevation by a novel Mdmx-p53 interaction inhibitor mitigates neuronal damage after ischemic stroke. Sci Rep. 2022;12:21110.","journal-title":"Sci Rep"},{"key":"1904_CR137","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1021\/acschemneuro.3c00250","volume":"14","author":"YY Zhang","year":"2023","unstructured":"Zhang YY, Peng JJ, Chen D, Liu HQ, Yao BF, Peng J, et al. Telaprevir improves memory and cognition in mice suffering ischemic stroke via targeting MALT1-mediated calcium overload and necroptosis. ACS Chem Neurosci. 2023;14:3113\u201324.","journal-title":"ACS Chem Neurosci"},{"key":"1904_CR138","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s44321-025-00206-6","volume":"17","author":"F Mei","year":"2025","unstructured":"Mei F, Deng D, Cao Z, Lou L, Chen K, Hu M, et al. Deubiquitination of RIPK3 by OTUB2 potentiates neuronal necroptosis after ischemic stroke. EMBO Mol Med. 2025;17:679\u201395.","journal-title":"EMBO Mol Med"},{"key":"1904_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2023.109502","volume":"735","author":"ZM Peng","year":"2023","unstructured":"Peng ZM, Zhang YY, Wei D, Zhang XJ, Liu B, Peng J, et al. MALT1 promotes necroptosis in stroke rat brain via targeting the A20\/RIPK3 pathway. Arch Biochem Biophys. 2023;735:109502.","journal-title":"Arch Biochem Biophys"},{"key":"1904_CR140","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00210-019-01656-9","volume":"392","author":"YY Zhang","year":"2019","unstructured":"Zhang YY, Liu WN, Li YQ, Zhang XJ, Yang J, Luo XJ, et al. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1\/RIPK3\/MLKL pathway. Naunyn Schmiedebergs Arch Pharmacol. 2019;392:1085\u201395.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1904_CR141","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1021\/acsptsci.4c00421","volume":"7","author":"H Inuzuka","year":"2024","unstructured":"Inuzuka H, Qian C, Qi Y, Xiong Y, Wang C, Wang Z, et al. Targeted degradation of receptor-interacting protein kinase 1 to modulate the necroptosis pathway. ACS Pharmacol Transl Sci. 2024;7:3518\u201326.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1904_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55006-2","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu X, Lu D, Qi X, Paudel RR, Lin H, Holloman BL, et al. Development of a RIPK1 degrader to enhance antitumor immunity. Nat Commun. 2024;15:10683.","journal-title":"Nat Commun"},{"key":"1904_CR143","doi-asserted-by":"publisher","first-page":"15353","DOI":"10.1021\/acs.jmedchem.4c00949","volume":"67","author":"S Li","year":"2024","unstructured":"Li S, Ma L, Li X, Jiang Y, Luo Z, Yin F, et al. Discovery of covalent MLKL PROTAC degraders via optimization of a theophylline derivative ligand for treating necroptosis. J Med Chem. 2024;67:15353\u201372.","journal-title":"J Med Chem"},{"key":"1904_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2025.103067","volume":"161","author":"JJ Peng","year":"2025","unstructured":"Peng JJ, Zhang YY, Li RF, Zhu WJ, Liu HR, Li HY, et al. Hybrid approach for drug-target interaction predictions in ischemic stroke models. Artif Intell Med. 2025;161:103067.","journal-title":"Artif Intell Med"},{"key":"1904_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109048","volume":"35","author":"MR Williamson","year":"2021","unstructured":"Williamson MR, Fuertes CJA, Dunn AK, Drew MR, Jones TA. Reactive astrocytes facilitate vascular repair and remodeling after stroke. Cell Rep. 2021;35:109048.","journal-title":"Cell Rep"},{"key":"1904_CR146","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41593-024-01684-6","volume":"27","author":"TM O\u2019Shea","year":"2024","unstructured":"O\u2019Shea TM, Ao Y, Wang S, Ren Y, Cheng AL, Kawaguchi R, et al. Derivation and transcriptional reprogramming of border-forming wound repair astrocytes after spinal cord injury or stroke in mice. Nat Neurosci. 2024;27:1505\u201321.","journal-title":"Nat Neurosci"},{"key":"1904_CR147","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev-biophys-111622-091300","volume":"52","author":"A Chari","year":"2023","unstructured":"Chari A, Stark H. Prospects and limitations of high-resolution single-particle cryo-electron microscopy. Annu Rev Biophys. 2023;52:391\u2013411.","journal-title":"Annu Rev Biophys"},{"key":"1904_CR148","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:217.","journal-title":"Signal Transduct Target Ther"},{"key":"1904_CR149","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.tibtech.2024.12.008","volume":"43","author":"M Yew","year":"2025","unstructured":"Yew M, Yang Y, Wang Q, Zhu L. High-throughput screening strategies for plastic-depolymerizing enzymes. Trends Biotechnol. 2025;43:1550\u201365.","journal-title":"Trends Biotechnol"},{"key":"1904_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2023.102548","volume":"79","author":"C Isert","year":"2023","unstructured":"Isert C, Atz K, Schneider G. Structure-based drug design with geometric deep learning. Curr Opin Struct Biol. 2023;79:102548.","journal-title":"Curr Opin Struct Biol"},{"key":"1904_CR151","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.tibs.2023.01.008","volume":"48","author":"ZZ Wang","year":"2023","unstructured":"Wang ZZ, Shi XX, Huang GY, Hao GF, Yang GF. Fragment-based drug discovery supports drugging \u2018undruggable\u2019 protein\u2013protein interactions. Trends Biochem Sci. 2023;48:539\u201352.","journal-title":"Trends Biochem Sci"},{"key":"1904_CR152","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406407121","volume":"121","author":"A Omidi","year":"2024","unstructured":"Omidi A, M\u00f8ller MH, Malhis N, Bui JM, Gsponer J. AlphaFold-Multimer accurately captures interactions and dynamics of intrinsically disordered protein regions. Proc Natl Acad Sci USA. 2024;121:e2406407121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1904_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23014-1","volume":"12","author":"B Wei","year":"2022","unstructured":"Wei B, Zhang Y, Gong X. DeepLPI: a novel deep learning-based model for protein-ligand interaction prediction for drug repurposing. Sci Rep. 2022;12:18200.","journal-title":"Sci Rep"},{"key":"1904_CR154","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.drudis.2022.01.013","volume":"27","author":"R Sakate","year":"2022","unstructured":"Sakate R, Kimura T. Drug repositioning trends in rare and intractable diseases. Drug Discov Today. 2022;27:1789\u201395.","journal-title":"Drug Discov Today"},{"key":"1904_CR155","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1080\/14796694.2024.2377530","volume":"20","author":"EP Hamilton","year":"2024","unstructured":"Hamilton EP, Ma C, De Laurentiis M, Iwata H, Hurvitz SA, Wander SA, et al. VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+\/HER2- advanced breast cancer. Future Oncol. 2024;20:2447\u201355.","journal-title":"Future Oncol"},{"key":"1904_CR156","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMoa2505725","volume":"393","author":"M Campone","year":"2025","unstructured":"Campone M, De Laurentiis M, Jhaveri K, Hu X, Ladoire S, Patsouris A, et al. Vepdegestrant, a PROTAC estrogen receptor degrader, in advanced breast cancer. N Engl J Med. 2025;393:556\u201368.","journal-title":"N Engl J Med"},{"key":"1904_CR157","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1158\/1535-7163.MCT-23-0655","volume":"24","author":"LB Snyder","year":"2025","unstructured":"Snyder LB, Neklesa TK, Willard RR, Gordon DA, Pizzano J, Vitale N, et al. Preclinical evaluation of bavdegalutamide (ARV-110), a novel PROteolysis TArgeting chimera androgen receptor degrader. Mol Cancer Ther. 2025;24:511\u201322.","journal-title":"Mol Cancer Ther"},{"key":"1904_CR158","doi-asserted-by":"publisher","first-page":"9074","DOI":"10.1021\/jacs.5c00131","volume":"147","author":"R Dutta","year":"2025","unstructured":"Dutta R, Devarajan A, Talluri A, Das R, Thayumanavan S. Dual-action-only PROTACs. J Am Chem Soc. 2025;147:9074\u20138.","journal-title":"J Am Chem Soc"},{"key":"1904_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117986","volume":"298","author":"S Teke Tuncel","year":"2025","unstructured":"Teke Tuncel S, Erol Gunal S, Demir \u0130, Baysal \u0130, Erdem SS, Telli G, et al. Multitarget-directed carbamate and carbamothioate derivatives: cholinesterase and monoamine oxidase inhibition, anti-\u03b2-amyloid (A\u03b2) aggregation, antioxidant and blood-brain barrier permeation properties against Alzheimer\u2019s disease. Eur J Med Chem. 2025;298:117986.","journal-title":"Eur J Med Chem"},{"key":"1904_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120011","volume":"591","author":"I Arduino","year":"2020","unstructured":"Arduino I, Iacobazzi RM, Riganti C, Lopedota AA, Perrone MG, Lopalco A, et al. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: a first step of a potential strategy for the treatment of Alzheimer\u2019s disease. Int J Pharmacol. 2020;591:120011.","journal-title":"Int J Pharmacol"},{"key":"1904_CR161","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-19-3258","volume":"26","author":"P Kumthekar","year":"2020","unstructured":"Kumthekar P, Tang SC, Brenner AJ, Kesari S, Piccioni DE, Anders C, et al. ANG1005, a brain-penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases. Clin Cancer Res. 2020;26:2789\u201399.","journal-title":"Clin Cancer Res"},{"key":"1904_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03238-9","volume":"23","author":"M Zhao","year":"2025","unstructured":"Zhao M, Li Q, Chai Y, Rong R, He L, Zhang Y, et al. An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma. J Nanobiotechnol. 2025;23:173.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.119002","volume":"575","author":"S Zhang","year":"2020","unstructured":"Zhang S, Asghar S, Yang L, Hu Z, Chen Z, Shao F, et al. Borneol and poly (ethylene glycol) dual modified BSA nanoparticles as an itraconazole vehicle for brain targeting. Int J Pharmacol. 2020;575:119002.","journal-title":"Int J Pharmacol"},{"key":"1904_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114539","volume":"190","author":"J Wang","year":"2022","unstructured":"Wang J, Li Z, Pan M, Fiaz M, Hao Y, Yan Y, et al. Ultrasound-mediated blood-brain barrier opening: an effective drug delivery system for theranostics of brain diseases. Adv Drug Deliv Rev. 2022;190:114539.","journal-title":"Adv Drug Deliv Rev"},{"key":"1904_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122749","volume":"312","author":"A Xie","year":"2025","unstructured":"Xie A, Cheng G, Wu J, Li Z, Yu G, Zhu X, et al. Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer\u2019s disease. Biomaterials. 2025;312:122749.","journal-title":"Biomaterials"},{"key":"1904_CR166","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","volume":"348","author":"K Ogawa","year":"2022","unstructured":"Ogawa K, Kato N, Yoshida M, Hiu T, Matsuo T, Mizukami S, et al. Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain. J Control Release. 2022;348:34\u201341.","journal-title":"J Control Release"},{"key":"1904_CR167","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1016\/j.apsb.2023.06.011","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang H, Zhao F, Jiang Z, Cui Y, Ou M, et al. Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment. Acta Pharm Sin B. 2023;13:5107\u201320.","journal-title":"Acta Pharm Sin B"},{"key":"1904_CR168","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.xphs.2020.12.004","volume":"110","author":"Y Islam","year":"2021","unstructured":"Islam Y, Ehtezazi P, Cashmore A, Marinsalda E, Leach AG, Coxon CR, et al. The inclusion of a matrix metalloproteinase-9 responsive sequence in self-assembled peptide-based brain-targeting nanoparticles improves the efficiency of nanoparticles crossing the blood-brain barrier at elevated MMP-9 levels. J Pharmacol Sci. 2021;110:1349\u201364.","journal-title":"J Pharmacol Sci"},{"key":"1904_CR169","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.1021\/acsnano.8b04787","volume":"12","author":"X Guo","year":"2018","unstructured":"Guo X, Deng G, Liu J, Zou P, Du F, Liu F, et al. Thrombin-responsive, brain-targeting nanoparticles for improved stroke therapy. ACS Nano. 2018;12:8723\u201332.","journal-title":"ACS Nano"},{"key":"1904_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01583-7","volume":"20","author":"Y Ding","year":"2022","unstructured":"Ding Y, Jin Y, Peng T, Gao Y, Zang Y, He H, et al. Fabrication of multifunctional metal-organic frameworks nanoparticles via layer-by-layer self-assembly to efficiently discover PSD95-nNOS uncouplers for stroke treatment. J Nanobiotechnol. 2022;20:379.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR171","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S0140-6736(25)00194-1","volume":"405","author":"MD Hill","year":"2025","unstructured":"Hill MD, Goyal M, Demchuk AM, Menon BK, Field TS, Guest WC, et al. Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial. Lancet. 2025;405:560\u201370.","journal-title":"Lancet"},{"key":"1904_CR172","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(25)00193-X","volume":"405","author":"J Christenson","year":"2025","unstructured":"Christenson J, Hill MD, Swartz RH, Adams C, Benavente O, Casaubon LK, et al. Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study. Lancet. 2025;405:571\u201382.","journal-title":"Lancet"},{"key":"1904_CR173","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.diabres.2018.02.021","volume":"139","author":"PS Rabbani","year":"2018","unstructured":"Rabbani PS, Ellison T, Waqas B, Sultan D, Abdou S, David JA, et al. Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds. Diab Res Clin Pract. 2018;139:11\u201323.","journal-title":"Diab Res Clin Pract"},{"key":"1904_CR174","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493\u2013500.","journal-title":"Nature"},{"key":"1904_CR175","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","volume":"620","author":"JL Watson","year":"2023","unstructured":"Watson JL, Juergens D, Bennett NR, Trippe BL, Yim J, Eisenach HE, et al. De novo design of protein structure and function with RFdiffusion. Nature. 2023;620:1089\u2013100.","journal-title":"Nature"},{"key":"1904_CR176","doi-asserted-by":"publisher","first-page":"W427","DOI":"10.1093\/nar\/gkad303","volume":"51","author":"H Tian","year":"2023","unstructured":"Tian H, Xiao S, Jiang X, Tao P. PASSer: fast and accurate prediction of protein allosteric sites. Nucleic Acids Res. 2023;51:W427\u2013W31.","journal-title":"Nucleic Acids Res"},{"key":"1904_CR177","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1021\/acs.jcim.1c00600","volume":"62","author":"V Bagal","year":"2022","unstructured":"Bagal V, Aggarwal R, Vinod PK, Priyakumar UD. MolGPT: molecular generation using a transformer-decoder model. J Chem Inf Model. 2022;62:2064\u201376.","journal-title":"J Chem Inf Model"},{"key":"1904_CR178","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","volume":"37","author":"T Nguyen","year":"2021","unstructured":"Nguyen T, Le H, Quinn TP, Nguyen T, Le TD, Venkatesh S. GraphDTA: predicting drug-target binding affinity with graph neural networks. Bioinformatics. 2021;37:1140\u20137.","journal-title":"Bioinformatics"},{"key":"1904_CR179","doi-asserted-by":"crossref","unstructured":"Jia Y, Gao B, Tan J, Zheng J, Hong X, Zhu W, et al. Deep contrastive learning enables genome-wide virtual screening. Science. 2026;391:eads9530.","DOI":"10.1126\/science.ads9530"},{"key":"1904_CR180","doi-asserted-by":"publisher","first-page":"10152","DOI":"10.1021\/acs.jcim.5c01753","volume":"65","author":"G Chen","year":"2025","unstructured":"Chen G, Liao J, Yu Y, Le K, Zhao H, Qin Y, et al. HitScreen: a sequence-based drug virtual screening approach using data augmentation and protein language models. J Chem Inf Model. 2025;65:10152\u201366.","journal-title":"J Chem Inf Model"},{"key":"1904_CR181","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49:W5\u2013W14.","journal-title":"Nucleic Acids Res"},{"key":"1904_CR182","doi-asserted-by":"publisher","first-page":"18164","DOI":"10.1021\/acsnano.3c05038","volume":"17","author":"C Li","year":"2023","unstructured":"Li C, Wu Y, Chen Q, Luo Y, Liu P, Zhou Z, et al. Pleiotropic microenvironment remodeling micelles for cerebral ischemia-reperfusion injury therapy by inhibiting neuronal ferroptosis and glial overactivation. ACS Nano. 2023;17:18164\u201377.","journal-title":"ACS Nano"},{"key":"1904_CR183","doi-asserted-by":"publisher","first-page":"7589","DOI":"10.7150\/thno.100930","volume":"14","author":"H Lu","year":"2024","unstructured":"Lu H, Zeng H, Wei W, Chen Y, Zhou Z, Ning X, et al. A fluorogenic ROS-triggered hydrogen sulfide donor for alleviating cerebral ischemia-reperfusion injury. Theranostics. 2024;14:7589\u2013603.","journal-title":"Theranostics"},{"key":"1904_CR184","doi-asserted-by":"publisher","first-page":"8680","DOI":"10.1021\/acsnano.3c01760","volume":"17","author":"R Prakash","year":"2023","unstructured":"Prakash R, Vyawahare A, Sakla R, Kumari N, Kumar A, Ansari MM, et al. NLRP3 inflammasome-targeting nanomicelles for preventing ischemia-reperfusion-induced inflammatory injury. ACS Nano. 2023;17:8680\u201393.","journal-title":"ACS Nano"},{"key":"1904_CR185","first-page":"57","volume":"16","author":"S Zhang","year":"2022","unstructured":"Zhang S, Peng B, Chen Z, Yu J, Deng G, Bao Y, et al. Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery. Bioact Mater. 2022;16:57\u201365.","journal-title":"Bioact Mater"},{"key":"1904_CR186","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jconrel.2024.02.039","volume":"368","author":"Y Li","year":"2024","unstructured":"Li Y, Liao J, Xiong L, Xiao Z, Ye F, Wang Y, et al. Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke. J Control Release. 2024;368:607\u201322.","journal-title":"J Control Release"},{"key":"1904_CR187","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410889","volume":"12","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ma X, Wang X, Liu L, Zhang X, Wang Q, et al. Traditional chinese medicine borneol-based polymeric micelles intracerebral drug delivery system for precisely pathogenesis-adaptive treatment of ischemic stroke. Adv Sci (Weinh). 2025;12:e2410889.","journal-title":"Adv Sci (Weinh)"},{"key":"1904_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123683","volume":"326","author":"X Ma","year":"2025","unstructured":"Ma X, Zhang X, Wang Y, Xu Y, Liu L, Li W, et al. Dynamic ROS-responsive hyperbranched polymer-based neuroprotective drug delivery system for pathogenesis-adaptive sequential therapy of cerebral ischemic stroke. Biomaterials. 2025;326:123683.","journal-title":"Biomaterials"},{"key":"1904_CR189","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301348","volume":"10","author":"Q Mu","year":"2023","unstructured":"Mu Q, Yao K, Syeda MZ, Zhang M, Cheng Q, Zhang Y, et al. Ligustrazine nanoparticle hitchhiking on neutrophils for enhanced therapy of cerebral ischemia-reperfusion injury. Adv Sci. 2023;10:e2301348.","journal-title":"Adv Sci"},{"key":"1904_CR190","doi-asserted-by":"publisher","first-page":"17845","DOI":"10.1021\/acsnano.3c03390","volume":"17","author":"S Sun","year":"2023","unstructured":"Sun S, Lv W, Li S, Zhang Q, He W, Min Z, et al. Smart liposomal nanocarrier enhanced the treatment of ischemic stroke through neutrophil extracellular traps and cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) pathway inhibition of ischemic penumbra. ACS Nano. 2023;17:17845\u201357.","journal-title":"ACS Nano"},{"key":"1904_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113955","volume":"385","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhang J, Zhang S, Yang W, Yang W, Guo J, et al. Dual-barrier traversing liposomes with ROS-responsive rigidity tuning for oral ischemic stroke therapy. J Control Release. 2025;385:113955.","journal-title":"J Control Release"},{"key":"1904_CR192","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309517","volume":"11","author":"YQ Geng","year":"2024","unstructured":"Geng YQ, Qiu LN, Cheng YQ, Li JJ, Ma YL, Zhao CC, et al. Alleviating recombinant tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke via targeted delivery of a ferroptosis inhibitor. Adv Sci. 2024;11:e2309517.","journal-title":"Adv Sci"},{"key":"1904_CR193","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202210144","volume":"36","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhao Y, Hou Y, Tang G, Zhang R, Yang Y, et al. A thrombin-activated peptide-templated nanozyme for remedying ischemic stroke via thrombolytic and neuroprotective actions. Adv Mater. 2024;36:e2210144.","journal-title":"Adv Mater"},{"key":"1904_CR194","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1021\/acsnano.2c11363","volume":"17","author":"Q Yang","year":"2023","unstructured":"Yang Q, Pu W, Hu K, Hu Y, Feng Z, Cai J, et al. Reactive oxygen species-responsive transformable and triple-Targeting butylphthalide nanotherapy for precision treatment of ischemic stroke by normalizing the pathological microenvironment. ACS Nano. 2023;17:4813\u201333.","journal-title":"ACS Nano"},{"key":"1904_CR195","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02641-y","volume":"22","author":"Y Liang","year":"2024","unstructured":"Liang Y, Fan T, Bai M, Cui N, Li W, Wang J, et al. Chikusetsu Saponin IVa liposomes modified with a retro-enantio peptide penetrating the blood-brain barrier to suppress pyroptosis in acute ischemic stroke rats. J Nanobiotechnol. 2024;22:393.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR196","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03251-y","volume":"23","author":"X Fu","year":"2025","unstructured":"Fu X, Zhang Y, Chen G, Mao G, Tang J, Xu J, et al. Responsive nanoparticles synergize with curcumin to break the \u201creactive oxygen species-neuroinflammation\u201d vicious cycle, enhancing traumatic brain injury outcomes. J Nanobiotechnol. 2025;23:172.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123479","volume":"324","author":"P Zhang","year":"2026","unstructured":"Zhang P, Wang Y, Xu Y, Li X, Yu X, Li Y, et al. Nasal-to-brain delivery of CCR5 antagonist for reshaping the dysregulated microglia-neuron axis and enhancing post-traumatic cognitive function. Biomaterials. 2026;324:123479.","journal-title":"Biomaterials"},{"key":"1904_CR198","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308719","volume":"11","author":"Q Mu","year":"2024","unstructured":"Mu Q, Yao K, Syeda MZ, Wan J, Cheng Q, You Z, et al. Neutrophil targeting platform reduces neutrophil extracellular traps for improved traumatic brain injury and stroke theranostics. Adv Sci. 2024;11:e2308719.","journal-title":"Adv Sci"},{"key":"1904_CR199","doi-asserted-by":"publisher","first-page":"15724","DOI":"10.1021\/acsnano.3c03232","volume":"17","author":"F Yang","year":"2023","unstructured":"Yang F, Zhao D, Cheng M, Liu Y, Chen Z, Chang J, et al. mTOR-mediated immunometabolic reprogramming nanomodulators enable sensitive switching of energy deprivation-induced microglial polarization for Alzheimer\u2019s disease management. ACS Nano. 2023;17:15724\u201341.","journal-title":"ACS Nano"},{"key":"1904_CR200","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401731","volume":"11","author":"X He","year":"2024","unstructured":"He X, Peng Y, Huang S, Xiao Z, Li G, Zuo Z, et al. Blood brain barrier-crossing delivery of felodipine nanodrug ameliorates anxiety-like behavior and cognitive impairment in Alzheimer\u2019s disease. Adv Sci. 2024;11:e2401731.","journal-title":"Adv Sci"},{"key":"1904_CR201","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.apsb.2021.04.022","volume":"11","author":"T Lei","year":"2021","unstructured":"Lei T, Yang Z, Xia X, Chen Y, Yang X, Xie R, et al. A nanocleaner specifically penetrates the blood-brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer\u2019s disease. Acta Pharm Sin B. 2021;11:4032\u201344.","journal-title":"Acta Pharm Sin B"},{"key":"1904_CR202","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apsb.2025.01.015","volume":"15","author":"Y Wei","year":"2025","unstructured":"Wei Y, Xia X, Wang X, Yang W, He S, Wang L, et al. Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer\u2019s disease. Acta Pharm Sin B. 2025;15:1098\u2013111.","journal-title":"Acta Pharm Sin B"},{"key":"1904_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113604","volume":"381","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yang X, Li J, Luo H, Huang Q, Yang W, et al. A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer\u2019s disease combination therapy. J Control Release. 2025;381:113604.","journal-title":"J Control Release"},{"key":"1904_CR204","volume":"19","author":"K Liang","year":"2024","unstructured":"Liang K, Yang L, Kang J, Liu B, Zhang D, Wang L, et al. Improving treatment for Parkinson\u2019s disease: harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier. Asian J Pharm Sci. 2024;19:100963.","journal-title":"Asian J Pharm Sci"},{"key":"1904_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123345","volume":"321","author":"L Zhai","year":"2025","unstructured":"Zhai L, Gao Y, Yang H, Wang H, Liao B, Cheng Y, et al. A ROS-responsive nanoparticle for nuclear gene delivery and autophagy restoration in Parkinson\u2019s disease therapy. Biomaterials. 2025;321:123345.","journal-title":"Biomaterials"},{"key":"1904_CR206","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jconrel.2022.12.024","volume":"353","author":"G Cheng","year":"2023","unstructured":"Cheng G, Li Z, Liu Y, Ma R, Chen X, Liu W, et al. Swiss Army Knife\u201d black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment. J Control Release. 2023;353:752\u201366.","journal-title":"J Control Release"},{"key":"1904_CR207","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02008-9","volume":"21","author":"Z Liu","year":"2023","unstructured":"Liu Z, Chen B, Xiang S, Hu S. Self-immolative nanocapsules precisely regulate depressive neuronal microenvironment for synergistic antidepression therapy. J Nanobiotechnol. 2023;21:274.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR208","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104286","volume":"9","author":"X He","year":"2022","unstructured":"He X, Xie J, Zhang J, Wang X, Jia X, Yin H, et al. Acid-responsive dual-targeted nanoparticles encapsulated aspirin rescue the immune activation and phenotype in autism spectrum disorder. Adv Sci. 2022;9:e2104286.","journal-title":"Adv Sci"},{"key":"1904_CR209","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03760-w","volume":"23","author":"Y Shen","year":"2025","unstructured":"Shen Y, Yu L, Wang L, Jin J, Yu C, Fan Y, et al. Biomimetic ferritin nanocages for synergistic co-delivery of metformin and rapamycin restore neurodevelopmental homeostasis in autism spectrum disorders. J Nanobiotechnol. 2025;23:670.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR210","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202300395","volume":"19","author":"Q Guan","year":"2023","unstructured":"Guan Q, Wang X, Cao D, Li M, Luo Z, Mao X. Calcium phosphate-based nanoformulation selectively abolishes phenytoin resistance in epileptic neurons for ceasing seizures. Small. 2023;19:e2300395.","journal-title":"Small"},{"key":"1904_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123216","volume":"319","author":"R Wei","year":"2025","unstructured":"Wei R, Xie K, Li T, Lin W, Zhao Y, Li J, et al. Immunity\/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12\/CXCR4 and adenosine-A2AR pathways. Biomaterials. 2025;319:123216.","journal-title":"Biomaterials"},{"key":"1904_CR212","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1016\/j.apsb.2025.03.018","volume":"15","author":"Y Guo","year":"2025","unstructured":"Guo Y, Fang M, Zhang S, Zhou Z, Tian Z, You H, et al. PROTAC-loaded nanocapsules degrading BRD4 for radio-chemotherapy sensitization in glioblastoma. Acta Pharm Sin B. 2025;15:5050\u201370.","journal-title":"Acta Pharm Sin B"},{"key":"1904_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101122","volume":"76","author":"Y Lan","year":"2024","unstructured":"Lan Y, Li X, Liu B, Lu J, Zuo B, Wang Y, et al. Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma. Drug Resist Updat. 2024;76:101122.","journal-title":"Drug Resist Updat"},{"key":"1904_CR214","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309314","volume":"11","author":"H Zhang","year":"2024","unstructured":"Zhang H, Jiang W, Song T, Song M, Liu S, Zhou J, et al. Lipid-polymer nanoparticles mediate compartmentalized delivery of Cas9 and sgRNA for glioblastoma vasculature and immune reprogramming. Adv Sci. 2024;11:e2309314.","journal-title":"Adv Sci"},{"key":"1904_CR215","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02776-y","volume":"22","author":"J Qi","year":"2024","unstructured":"Qi J, Zhang L, Ren Z, Yuan Y, Yu J, Zhang Y, et al. Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy. J Nanobiotechnol. 2024;22:495.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR216","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1021\/acsnano.3c11958","volume":"18","author":"S Jiang","year":"2024","unstructured":"Jiang S, Li W, Yang J, Zhang T, Zhang Y, Xu L, et al. Cathepsin B-responsive programmed brain targeted delivery system for chemo-immunotherapy combination therapy of glioblastoma. ACS Nano. 2024;18:6445\u201362.","journal-title":"ACS Nano"},{"key":"1904_CR217","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jconrel.2020.10.043","volume":"329","author":"Q Fan","year":"2021","unstructured":"Fan Q, Liu Y, Cui G, Zhong Z, Deng C. Brain delivery of Plk1 inhibitor via chimaeric polypeptide polymersomes for safe and superb treatment of orthotopic glioblastoma. J Control Release. 2021;329:1139\u201349.","journal-title":"J Control Release"},{"key":"1904_CR218","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr8841","volume":"11","author":"Z Li","year":"2025","unstructured":"Li Z, Jiang S, Wang J, Li W, Yang J, Liu W, et al. Peptide-drug conjugates repolarize glioblastoma-associated macrophages to resensitize chemo-immunotherapy of glioblastoma. Sci Adv. 2025;11:eadr8841.","journal-title":"Sci Adv"},{"key":"1904_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122708","volume":"311","author":"J Li","year":"2024","unstructured":"Li J, Yang J, Jiang S, Tian Y, Zhang Y, Xu L, et al. Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy. Biomaterials. 2024;311:122708.","journal-title":"Biomaterials"},{"key":"1904_CR220","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1021\/acsnano.4c05906","volume":"19","author":"JL Meng","year":"2025","unstructured":"Meng JL, Dong ZX, Chen YR, Lin MH, Liu YC, Roffler SR, et al. pH-responsive polyethylene glycol engagers for enhanced brain delivery of PEGylated nanomedicine to treat glioblastoma. ACS Nano. 2025;19:307\u201321.","journal-title":"ACS Nano"},{"key":"1904_CR221","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jconrel.2024.01.004","volume":"368","author":"K Xue","year":"2024","unstructured":"Xue K, Yang R, An Y, Ding Y, Li S, Miao F, et al. NIR-promoted ferrous ion regeneration enhances ferroptosis for glioblastoma treatment. J Control Release. 2024;368:595\u2013606.","journal-title":"J Control Release"},{"key":"1904_CR222","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202516990","volume":"65","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li X, Zhu Q, Zhong Y, Lin X, Zhou C, et al. Brain-targeted near-infrared chiral TeSe nanodrug against orthotopic drug-resistant glioma. Angew Chem Int Ed Engl. 2025;65:e202516990.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1904_CR223","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202008802","volume":"33","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang W, Mohammadniaei M, Zheng T, Zhang Q, Ashley J, et al. Upregulating aggregation-induced-emission nanoparticles with blood-tumor-barrier permeability for precise photothermal eradication of brain tumors and induction of local immune responses. Adv Mater. 2021;33:e2008802.","journal-title":"Adv Mater"},{"key":"1904_CR224","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202314197","volume":"36","author":"Z Wang","year":"2024","unstructured":"Wang Z, Chen F, Cao Y, Zhang F, Sun L, Yang C, et al. An engineered nanoplatform with tropism toward irradiated glioblastoma augments its radioimmunotherapy efficacy. Adv Mater. 2024;36:e2314197.","journal-title":"Adv Mater"},{"key":"1904_CR225","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202501620","volume":"21","author":"X Zhang","year":"2025","unstructured":"Zhang X, Wang B, Qi X, Qian Z, Gao X, Cheng Y, et al. A glutathione-responsive system with prodrug and sensitization strategies for targeted therapy of glioma. Small. 2025;21:e2501620.","journal-title":"Small"},{"key":"1904_CR226","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01731-z","volume":"20","author":"P Zhao","year":"2022","unstructured":"Zhao P, Tian Y, Lu Y, Zhang J, Tao A, Xiang G, et al. Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis. J Nanobiotechnol. 2022;20:525.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR227","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jconrel.2022.10.037","volume":"352","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang M, Zhang Q, Mohammadniaei M, Shen J, Sun Y. Brain-targeted antigen-generating nanoparticles improve glioblastoma prognosis. J Control Release. 2022;352:399\u2013410.","journal-title":"J Control Release"},{"key":"1904_CR228","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03182-8","volume":"23","author":"C Zou","year":"2025","unstructured":"Zou C, Liu X, Wang W, He L, Yin A, Cao Z, et al. Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles. J Nanobiotechnol. 2025;23:126.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR229","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202205354","volume":"19","author":"W Jia","year":"2023","unstructured":"Jia W, Tian H, Jiang J, Zhou L, Li L, Luo M, et al. Brain-targeted HFn-Cu-REGO nanoplatform for site-specific delivery and manipulation of autophagy and cuproptosis in glioblastoma. Small. 2023;19:e2205354.","journal-title":"Small"},{"key":"1904_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122006","volume":"294","author":"G Catania","year":"2023","unstructured":"Catania G, Rodella G, Vanvarenberg K, Pr\u00e9at V, Malfanti A. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival. Biomaterials. 2023;294:122006.","journal-title":"Biomaterials"},{"key":"1904_CR231","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206333","volume":"10","author":"J Zhang","year":"2023","unstructured":"Zhang J, Han L, Wu H, Zhong Y, Shangguan P, Liu Y, et al. A brain-targeting NIR-II ferroptosis system: effective visualization and oncotherapy for orthotopic glioblastoma. Adv Sci. 2023;10:e2206333.","journal-title":"Adv Sci"},{"key":"1904_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64020-x","volume":"16","author":"T Chen","year":"2025","unstructured":"Chen T, Duan Y, Wang Y, Liang T, Liu S, Xia X, et al. Size-variable self-feedback nanomotors for glioblastoma therapy via mitochondrial mineralization. Nat Commun. 2025;16:8990.","journal-title":"Nat Commun"},{"key":"1904_CR233","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1021\/acsnano.3c01428","volume":"17","author":"J Kuang","year":"2023","unstructured":"Kuang J, Rao ZY, Zheng DW, Kuang D, Huang QX, Pan T, et al. Nanoparticles hitchhike on monocytes for glioblastoma treatment after low-dose radiotherapy. ACS Nano. 2023;17:13333\u201347.","journal-title":"ACS Nano"},{"key":"1904_CR234","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202411689","volume":"21","author":"W Lin","year":"2025","unstructured":"Lin W, Wei R, Lai S, Li J, Zhao Y, Lin J, et al. Acid-responsive disassembly of nanomedicines for extracellular drug delivery reversing glioblastoma immunosuppressive microenvironment by targeting the adenosine-A2AR pathway. Small. 2025;21:e2411689.","journal-title":"Small"},{"key":"1904_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123730","volume":"327","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, Chen J, Kang Y, Ding Z, Jin C, Gan Z, et al. Dual-responsive nanoparticle system for enhanced blood-brain barrier crossing and glioblastoma penetration. Biomaterials. 2025;327:123730.","journal-title":"Biomaterials"},{"key":"1904_CR236","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02531-3","volume":"22","author":"X Chen","year":"2024","unstructured":"Chen X, Zheng Y, Zhang Q, Chen Q, Chen Z, Wu D. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma. J Nanobiotechnol. 2024;22:264.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR237","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.apsb.2022.05.016","volume":"12","author":"F Li","year":"2022","unstructured":"Li F, Lai Y, Ye J, Saeed M, Dang Y, Zou Z, et al. Dual-targeting prodrug nanotheranostics for NIR-\u2161 fluorescence imaging-guided photo-immunotherapy of glioblastoma. Acta Pharm Sin B. 2022;12:3486\u201397.","journal-title":"Acta Pharm Sin B"},{"key":"1904_CR238","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311500","volume":"36","author":"Y Xiang","year":"2024","unstructured":"Xiang Y, Wang B, Yang W, Zheng X, Chen R, Gong Q, et al. Mitocytosis mediated by an enzyme-activable mitochondrion-disturbing polymer-drug conjugate enhances active penetration in glioblastoma therapy. Adv Mater. 2024;36:e2311500.","journal-title":"Adv Mater"},{"key":"1904_CR239","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202400502","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ma H, Li L, Sun C, Yu C, Wang L, et al. Dual-targeted novel temozolomide nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize glioblastoma to chemotherapy. Adv Mater. 2024;36:e2400502.","journal-title":"Adv Mater"},{"key":"1904_CR240","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2024.02.004","volume":"368","author":"R Wang","year":"2024","unstructured":"Wang R, Song W, Zhu J, Shao X, Yang C, Xiong W, et al. Biomimetic nano-chelate diethyldithiocarbamate Cu\/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy. J Control Release. 2024;368:84\u201396.","journal-title":"J Control Release"},{"key":"1904_CR241","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jconrel.2024.04.006","volume":"369","author":"L Tang","year":"2024","unstructured":"Tang L, Zhang R, Wang Y, Liu M, Hu D, Wang Y, et al. A blood-brain barrier- and blood-brain tumor barrier-penetrating siRNA delivery system targeting gliomas for brain tumor immunotherapy. J Control Release. 2024;369:642\u201357.","journal-title":"J Control Release"},{"key":"1904_CR242","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202400630","volume":"20","author":"W Zhuo","year":"2024","unstructured":"Zhuo W, Wang W, Zhou W, Duan Z, He S, Zhang X, et al. A targeted and responsive nanoprodrug delivery system for synergistic glioma chemotherapy. Small. 2024;20:e2400630.","journal-title":"Small"},{"key":"1904_CR243","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jconrel.2022.08.019","volume":"350","author":"Y Shen","year":"2022","unstructured":"Shen Y, Hu M, Li W, Chen Y, Xu Y, Sun L, et al. Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy. J Control Release. 2022;350:158\u201374.","journal-title":"J Control Release"},{"key":"1904_CR244","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02376-w","volume":"22","author":"X Li","year":"2024","unstructured":"Li X, Cheng Y, Yang Z, Ji Q, Huan M, Ye W, et al. Glioma-targeted oxaliplatin\/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction. J Nanobiotechnol. 2024;22:93.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR245","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409753","volume":"11","author":"L Yi","year":"2024","unstructured":"Yi L, Zhang Z, Zhou W, Zhang Y, Hu Y, Guo A, et al. BRD4 degradation enhanced glioma sensitivity to temozolomide by regulating Notch1 via Glu-Modified GSH-responsive nanoparticles. Adv Sci. 2024;11:e2409753.","journal-title":"Adv Sci"},{"key":"1904_CR246","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54382-z","volume":"15","author":"B Li","year":"2024","unstructured":"Li B, Chen G, Zhong H, Li T, Lin M, Wei H, et al. \u03b3-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma. Nat Commun. 2024;15:10418.","journal-title":"Nat Commun"},{"key":"1904_CR247","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1016\/j.apsb.2022.11.003","volume":"13","author":"F Tong","year":"2023","unstructured":"Tong F, Hu H, Xu Y, Zhou Y, Xie R, Lei T, et al. Hollow copper sulfide nanoparticles carrying ISRIB for the sensitized photothermal therapy of breast cancer and brain metastases through inhibiting stress granule formation and reprogramming tumor-associated macrophages. Acta Pharm Sin B. 2023;13:3471\u201388.","journal-title":"Acta Pharm Sin B"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01904-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01904-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01904-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:02:46Z","timestamp":1786348966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01904-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":247,"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01904-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}